Results 41 to 50 of about 16,231 (238)
Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire. [PDF]
BACKGROUND: The development of a patient-reported outcome measure (PROM) for polymyalgia rheumatica (PMR), a condition that causes pain, stiffness and disability, is necessary as there is no current validated disease-specific measure.
B Dasgupta+14 more
core +4 more sources
1. Polymyalgia rheumatica is a disease of unknown cause, manifested by severe pain and stiffness of the muscles of the shoulder and pelvic girdles, which may be accompanied by a variety of other systemic symptoms. 2. Twenty-three patients with this condition are reviewed. 3. The difficulties of diagnosis, especially when presenting as an orthopaedic
A G, Mowat, A V, Camp
openaire +2 more sources
What is the absolute risk of developing diabetes mellitus in patients with glucocorticoid-treated polymyalgia rheumatica and giant cell arteritis? a systematic review and meta-analysis [PDF]
Background: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are treated with glucocorticoids (GCs) but long-term GC use is associated with diabetes mellitus (DM).
Harris, Emma+3 more
core +1 more source
Severe cholestatic hepatitis due to large vessel vasculitis: report of two cases [PDF]
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesGiant cell arteritis (GCA) is a vasculitis of medium and large sized vessels ...
Björnsson, Einar S.+2 more
core +1 more source
Background Polymyalgia rheumatica is an inflammatory disease characterized by stiffness and pain around the proximal muscles of both arms and hips and a peak incidence in adults over 50 years of age.
Yasser El Miedany+6 more
doaj +1 more source
Objective An unmet need exists for glucocorticoid‐sparing treatments for patients with polymyalgia rheumatica (PMR). The antibody‐drug conjugate ABBV‐154 comprises adalimumab conjugated to a glucocorticoid receptor modulator. We evaluated ABBV‐154 versus placebo in patients with glucocorticoid‐dependent PMR.
Robert F. Spiera+14 more
wiley +1 more source
New insights into the pathogenesis of giant cell arteritis [PDF]
Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an ...
Francesco Ciccia+110 more
core +3 more sources
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim+5 more
wiley +1 more source
The existence of polymyalgia rheumatica (PMR) induced by statins has been hypothesised by some investigators. This review article highlights the fact that there is no evidence it is real.
Ciro Manzo
doaj +1 more source
Enlarging Liver Mass: Inflammatory Pseudotumor in a Patient With Polymyalgia Rheumatica
Inflammatory pseudotumors of the liver are rare, non-neoplastic liver tumors. Due to the nonspecific clinical presentation, imaging features, and histopathological findings, they can mimic malignant tumors requiring invasive diagnostics.
Gowthami Kanagalingam MD+6 more
doaj +1 more source